OMG Pharma

OMG Pharma is an Australian medicinal biotechnology company and a division of the Oz Medicann Group (OMG), specializing in the development of evidence-led natural medicines and cannabinoid-based biopharmaceuticals. Founded in 2017, the company focuses on translating rigorous scientific research into prescription-grade therapeutics for high-burden conditions including sleep disorders, chronic pain, and metabolic health. OMG Pharma's pipeline features innovative delivery formats such as sublingual orally dispersible tablets for insomnia and topical salves for rheumatoid arthritis. Through strategic partnerships with global leaders like dsm-firmenich and academic institutions like the NICM Health Research Institute, the company aims to establish new standards for quality and clinical integrity in the medicinal cannabis sector. The company also operates a self-sustaining model by reinvesting revenues from its wellness brands into clinical research and product development.